ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.290,66
0,31%
S&P 500
5.475,09
0,27%
Dow Jones
39.169,52
0,13%
Euro vs US Dollar
1,07366
0,01%
Bitcoin
62.822,62
-0,04%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Impax Laboratories (MM) (IPXLE)

  7. Impax Laboratories (MM) (IPXLE) News

IPXLE

Impax labs (IPXLE)

Impax Laboratories (MM)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:IPXLE
DatumZeitQuelleÜberschriftSymbolFirma
19/01/201722h27Dow Jones NewsRival to EpiPen Allergy Treatment to Return to Market--UpdateNASDAQ:IPXLEImpax Laboratories (MM)
19/01/201721h17Dow Jones NewsRival to EpiPen Allergy Treatment to Return to MarketNASDAQ:IPXLEImpax Laboratories (MM)
12/01/201723h03Dow Jones NewsCigna Drops Coverage of Mylan's EpiPen for Cheaper Generic -- UpdateNASDAQ:IPXLEImpax Laboratories (MM)
03/11/201621h08Dow Jones NewsDOJ Looking Into Possible Price Collusion in Generic Drug Sector -BloombergNASDAQ:IPXLEImpax Laboratories (MM)
28/07/201601h41Dow Jones NewsCorrection to Teva, Allergan ArticleNASDAQ:IPXLEImpax Laboratories (MM)
27/07/201622h00Dow Jones NewsTeva, Allergan Get FTC Approval for Generics PurchaseNASDAQ:IPXLEImpax Laboratories (MM)
27/07/201621h51Dow Jones NewsTeva, Allergan Get FTC Approval for Generics PurchaseNASDAQ:IPXLEImpax Laboratories (MM)
13/07/201601h20Dow Jones NewsTeva Raises GuidanceNASDAQ:IPXLEImpax Laboratories (MM)
22/06/201609h07Dow Jones NewsBusiness Watch -- WSJNASDAQ:IPXLEImpax Laboratories (MM)
21/06/201615h30Dow Jones NewsTeva and Allergan Sell Generic Drugs to Impax In Latest DivestitureNASDAQ:IPXLEImpax Laboratories (MM)
21/06/201615h17Dow Jones NewsTeva and Allergan Sell Generic Drugs to Impax In Latest DivestitureNASDAQ:IPXLEImpax Laboratories (MM)
31/03/201617h50Dow Jones NewsFTC Accuses Endo of Paying Off Generic DrugmakersNASDAQ:IPXLEImpax Laboratories (MM)
23/09/201505h50Dow Jones NewsTuring to Cut Price of Drug Daraprim After OutcryNASDAQ:IPXLEImpax Laboratories (MM)
05/08/200510h00Business WireIMPAX Receives Notice of Delisting from NasdaqNASDAQ:IPXLEImpax Laboratories (MM)
05/08/200510h00Business WireIMPAX Receives Notice of Delisting from NasdaqNASDAQ:IPXLEImpax Laboratories (MM)
03/08/200510h00Business WireIMPAX Provides Further Update of Progress in Filing 10-K and 10-Q and Estimates of ResultsNASDAQ:IPXLEImpax Laboratories (MM)
03/08/200510h00Business WireIMPAX Provides Further Update of Progress in Filing 10-K and 10-Q and Estimates of ResultsNASDAQ:IPXLEImpax Laboratories (MM)
27/06/200513h00Business WireIMPAX Laboratories, Inc. Agrees to Sell $75 Million of 3.5% Senior Subordinated Convertible Debentures Due 2012; Proceeds to beNASDAQ:IPXLEImpax Laboratories (MM)
20/06/200514h01Business WireIMPAX to Increase Existing Credit FacilityNASDAQ:IPXLEImpax Laboratories (MM)
04/05/200515h03Business WireIMPAX Provides Updates on Progress to File 10-K and Related MattersNASDAQ:IPXLEImpax Laboratories (MM)
04/05/200515h03Business WireIMPAX Provides Updates on Progress to File 10-K and Related MattersNASDAQ:IPXLEImpax Laboratories (MM)
02/05/200517h01Business WireCORRECTING and REPLACING IMPAX Receives FDA Approval for Generic Version of Rimadyl, a Veterinary Product; Fourth Approval in 20NASDAQ:IPXLEImpax Laboratories (MM)
02/05/200515h24Business WireIMPAX Receives FDA Approval for Generic Version of Rimadyl, a Veterinary Product; Fourth Approval in 2005NASDAQ:IPXLEImpax Laboratories (MM)
 Showing the most relevant articles for your search:NASDAQ:IPXLE

Kürzlich von Ihnen besucht

NASDAQ
FLFVR
Feutune Light Acquisition
BIT
P1ZF06
NLBNPIT1ZF06 20991231 58...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten